Bactericidal and tumoricidal activities of synthetic peptides derived from granulysin

Journal of Immunology

Volumn 165, Issue 3, 2000, Pages 1486-1490

  Wang, Zhuo ^a   Choice, Edward ^a   Kaspar, Allan ^a   Hanson, Dennis ^a   Okada, Satoshi ^a   Lyu, Shu Chen ^a   Krensky, Alan M ^a   Clayberger, Carol ^a,b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; CELL PROTEIN; CYSTEINE; GLUTAMINE; GRANULYSIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CYTOLYSIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0034254495     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.3.1486     Document Type: Article

References (22)

1. Peña, S. V., D. A. Hanson, B. A. Carr, T. J. Goralski, and A. M. Krensky. 1997. Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J. Immunol. 158:2680.
2. Peña, S. V., and A. M. Krensky. 1997. Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin. Immunol. 9:117.
3. Hanson, D. A., A. A. Kaspar, F. R. Poulain, and A. M. Krensky. 1999. Biosynthesis of granulysin, a novel cytolytic molecule. Mol. Immunol. 36:413.
4. Gamen, S., D. A. Hanson, A. Kaspar, J. Naval, A. M. Krensky, and A. Anel. 1998. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J. Immunol. 161:1758.
5. Stenger, S., D. A. Hanson, R. Teitelbaum, P. Dewan, K. R. Niazi, C. J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melián, C. Bogdan, et al. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121.
6. Andersson, M., H. Gunne, B. Agerberth, A. Boman, T. Bergman, R. Sillard, H. Jörnvall, V. Mutt, B. Olsson, H. Wigzell, et al. 1995. NK-lysin, a novel effector peptide of cytotoxic T and NK cells: structure and cDNA cloning of the porcine form, induction by interleukin 2, antibacterial and antitumour activity. EMBO J. 14:1615.
7. Andersson, M., T. Curstedt, H. Jörnvall, and J. Johansson. 1995. An amphipathic helical motif common to tumourolytic polypeptide NK-lysin and pulmonary surfactant polypeptide SP-B. FEBS Lett. 362:328.
8. Liepinsh, E., M. Andersson, J. M. Ruysschaert, and G. Otting. 1997. Saposin fold revealed by the NMR structure of NK-lysin. Nat. Struc. Biol. 4:793.
9. Andersson, M., A. Holmgren, and G. Spyrou. 1996. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase: implication for a protective mechanism against NK-lysin cytotoxicity. J. Biol. Chem. 271:10116.
10. Dou, Q. P., B. An, K. Antoku, and D. E. Johnson. 1997. Fas stimulation induces RB dephosphorylation and proteolysis that is blocked by inhibitors of the ICE protease family. J. Cell Biochem. 64:586.
11. Chang, R., S. Nir, and F. R. Poulain. 1998. Analysis of binding and membrane destabilization of phospholipid membranes by surfactant apoprotein B. Biochem. Biophys. Acta 1371:254.
12. Andra, J., and M. Leippe. 1994. Pore-forming peptide of Entamoeba histolytica: significance of positively charged amino acid residues for its mode of action. FEBS Lett. 354:97.
13. Kini, R. M., and H. J. Evans. 1989. A common cytolytic region in myotoxins, hemolysins, cardiotoxins and antibacterial peptides. Int. J. Pep. Prot. Res. 34: 277.
14. Ray, C. A., R. A. Black, S. R. Kronheim, T. A. Greenstreet, P. R. Sleath, G. S. Salvesen, and D. J. Pickup. 1992. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69:597.
15. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281: 1309.
16. Rudin, C. M., and C. B. Thompson. 1997. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu. Rev. Med. 48:267.
17. Stenger, S., R. J. Mazzaccaro, K. Uyemura, S. Cho, P. F. Barnes, J. P. Rosat, A. Sette, M. B. Brenner, S. A. Porcelli, B. R. Bloom, and R. L. Modlin. 1997. Differential effects of cytolytic T cell subsets on intracellular infection. Science 276:1684.
18. Andreu, D., C. Carreño, C. Linde, H. G. Boman, and M. Andersson. 1999. Identification of an anti-mycobacterial domain in NK-lysin and granulysin. Biochem. J. 344:845.
19. Andreu, D., and L. Rivas. 1998. Animal antimicrobial peptides: an overview. Biopolymers 47:415.
20. Boman, H. G. 1995. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunoll. 13:61.
21. Ganz, T., and R. I. Lehrer. 1997. Antimicrobial peptides of leukocytes. Curr. Opin. Hemitol. 4:53.
22. Zhou, Q., S. Snipas, K. Orth, M. Muzio, V. M. Dixit, and G. S. Salvesen. 1997. Target protease specificity of the viral serpin CrmA: analysis of live caspases. J. Biol. Chem. 272:7797.